PL2342197T3 - Znakowane izotopowo inhibitory transportera glicyny 1 - Google Patents

Znakowane izotopowo inhibitory transportera glicyny 1

Info

Publication number
PL2342197T3
PL2342197T3 PL09737459T PL09737459T PL2342197T3 PL 2342197 T3 PL2342197 T3 PL 2342197T3 PL 09737459 T PL09737459 T PL 09737459T PL 09737459 T PL09737459 T PL 09737459T PL 2342197 T3 PL2342197 T3 PL 2342197T3
Authority
PL
Poland
Prior art keywords
transporter
glycine
radiolabelled
inhibitors
radiolabelled inhibitors
Prior art date
Application number
PL09737459T
Other languages
English (en)
Inventor
Daniela Alberati
Edilio Maurizio Borroni
Thomas Hartung
Roger Norcross
Emmanuel Pinard
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL2342197T3 publication Critical patent/PL2342197T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09737459T 2008-11-04 2009-10-26 Znakowane izotopowo inhibitory transportera glicyny 1 PL2342197T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08168229 2008-11-04
PCT/EP2009/064033 WO2010052143A1 (en) 2008-11-04 2009-10-26 Radiolabelled inhibitors of the glycine 1 transporter
EP09737459A EP2342197B1 (en) 2008-11-04 2009-10-26 Radiolabelled inhibitors of the glycine 1 transporter

Publications (1)

Publication Number Publication Date
PL2342197T3 true PL2342197T3 (pl) 2013-06-28

Family

ID=41402176

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09737459T PL2342197T3 (pl) 2008-11-04 2009-10-26 Znakowane izotopowo inhibitory transportera glicyny 1

Country Status (21)

Country Link
US (1) US8153679B2 (pl)
EP (1) EP2342197B1 (pl)
JP (1) JP5543477B2 (pl)
KR (1) KR101307671B1 (pl)
CN (1) CN102186844B (pl)
AR (1) AR074084A1 (pl)
AU (1) AU2009312891B2 (pl)
BR (1) BRPI0921795B8 (pl)
CA (1) CA2739869C (pl)
CL (1) CL2011000982A1 (pl)
DK (1) DK2342197T3 (pl)
ES (1) ES2401221T3 (pl)
IL (1) IL211804A (pl)
MX (1) MX2011004350A (pl)
PE (1) PE20110434A1 (pl)
PL (1) PL2342197T3 (pl)
RU (1) RU2512529C2 (pl)
SI (1) SI2342197T1 (pl)
TW (1) TWI449537B (pl)
WO (1) WO2010052143A1 (pl)
ZA (1) ZA201102521B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5618047B2 (ja) * 2010-01-29 2014-11-05 国立大学法人千葉大学 ポジトロン断層撮影法およびポジトロン放出化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53252B (en) 2003-08-11 2014-08-29 F.Hoffmann-La Roche Ag. PIPERAZINE WITH OR-SUBSTITUTED PHENYL GROUP AND THEIR USE AS GLYT1 INHIBITOR
MX2007009342A (es) * 2005-02-07 2007-09-21 Hoffmann La Roche Fenil-metanonas sustituidas por heterociclo como inhibidor del transportador 1 de glicina.
WO2007041025A2 (en) * 2005-09-29 2007-04-12 Merck & Co., Inc. Radiolabeled glycine transporter inhibitors

Also Published As

Publication number Publication date
SI2342197T1 (sl) 2013-05-31
AU2009312891A1 (en) 2010-05-14
US20100111862A1 (en) 2010-05-06
TW201019964A (en) 2010-06-01
IL211804A (en) 2013-11-28
TWI449537B (zh) 2014-08-21
KR20110063861A (ko) 2011-06-14
BRPI0921795A2 (pt) 2016-01-12
RU2512529C2 (ru) 2014-04-10
DK2342197T3 (da) 2013-02-18
BRPI0921795B8 (pt) 2021-07-27
CL2011000982A1 (es) 2012-02-03
CA2739869A1 (en) 2011-05-14
JP2012507486A (ja) 2012-03-29
CA2739869C (en) 2016-09-27
ES2401221T3 (es) 2013-04-17
ZA201102521B (en) 2012-09-29
EP2342197A1 (en) 2011-07-13
MX2011004350A (es) 2011-05-23
US8153679B2 (en) 2012-04-10
AU2009312891B2 (en) 2013-07-11
CN102186844B (zh) 2014-08-13
JP5543477B2 (ja) 2014-07-09
BRPI0921795B1 (pt) 2020-10-20
WO2010052143A1 (en) 2010-05-14
IL211804A0 (en) 2011-06-30
KR101307671B1 (ko) 2013-09-12
PE20110434A1 (es) 2011-07-01
RU2011118230A (ru) 2012-12-20
CN102186844A (zh) 2011-09-14
EP2342197B1 (en) 2013-01-16
AR074084A1 (es) 2010-12-22

Similar Documents

Publication Publication Date Title
ZA200907414B (en) Substituted Benzoylamino-indan-2-carboxylic acids and related compounds
EP2272817A4 (en) INHIBITOR OF PAI-1
HK1139936A1 (en) Substituted pyrimidodiazepines useful as plk1 inhibitors
IL197752A0 (en) Hdac inhibitors
EP2200439A4 (en) HDAC INHIBITORS
GB201000648D0 (en) Phosphodiesterase 10 inhibitors
EP2303890A4 (en) INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE
HK1134029A1 (en) Amino acid composition
HK1144070A1 (zh) 肽脫甲酰基酶抑制劑
EP2029448A4 (en) TRANSPORT APPARATUS
EP2409976A4 (en) GLYCINTRANSPORTERHEMMER
EP2023727A4 (en) PROSTAGLANDINTRANSPORTER INHIBITORS
ZA201004216B (en) Glycine transporter-1 inhibitors
IL195331A0 (en) Hsp90 inhibitor
GB0624187D0 (en) HDAC inhibitors
EP2454240A4 (en) GLYCINTRANSPORTERHEMMER
EP2501771A4 (en) CURABLE POLYAMIDES UNDER MOISTURE ACTION AND METHODS OF USE
ZA201102521B (en) Radiolabelled inhibitors of the glycine 1 transporter
EP2188305A4 (en) MODIFIED PEPTIDES HAVING TOXIN IMPROVING EFFECTS
ZA200810599B (en) Glycine transporter-1 inhibitors
ZA200809814B (en) HSP90 Inhibitor
GB0701952D0 (en) Compounds which inhibit the glycine transporter and uses thereof
GB0701949D0 (en) Compounds which inhibit the glycine transporter and uses thereof
GB0701987D0 (en) Compounds which inhibit the glycine transporter and uses thereof
GB0701959D0 (en) Compounds which inhibit the glycine transporter and uses thereof